Table of Contents

company-logo

Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in Redwood City, California.

Biomea Fusion Dividend Announcement

• Biomea Fusion does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Biomea Fusion dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Biomea Fusion Dividend History

Biomea Fusion Dividend Yield

Biomea Fusion current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Biomea Fusion stock? Use our calculator to estimate your expected dividend yield:

Biomea Fusion Financial Ratios

P/E ratio-1.74
PEG ratio0.03
P/B ratio3.30
ROE-118.90%
Payout ratio0.00%
Current ratio3.39
Quick ratio3.39
Cash Ratio3.19

Biomea Fusion Dividend FAQ

Does Biomea Fusion stock pay dividends?
Biomea Fusion does not currently pay dividends to its shareholders.
Has Biomea Fusion ever paid a dividend?
No, Biomea Fusion has no a history of paying dividends to its shareholders. Biomea Fusion is not known for its dividend payments.
Why doesn't Biomea Fusion pay dividends?
There are several potential reasons why Biomea Fusion would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Biomea Fusion ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Biomea Fusion has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Biomea Fusion a dividend aristocrat?
Biomea Fusion is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Biomea Fusion a dividend king?
Biomea Fusion is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Biomea Fusion a dividend stock?
No, Biomea Fusion is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Biomea Fusion stocks?
To buy Biomea Fusion you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Biomea Fusion stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.